Background illustration for clinical trials search

Weight Loss Clinical Trials

Find clinical trials for weight loss. Search for weight loss clinical trials in different cities and states across the United States.

Filter

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

for
Drug Discontinuation, Substance Use Disorders,
Location: Dallas TX
Sponsor: The University of Texas at Dallas

Sex: All

Age: 18 - 70

Code: NCT07387796

Recruiting

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

for
Longevity, GLP-1, Geroscience, Aging
Location: Chicago IL
Sponsor: AgelessRx

Sex: All

Age: 40 - 70+

Code: NCT07092618

Phase 2, Phase 3, Recruiting

Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Complete a Weight Loss Program, Half Get Scales at Baseline, Half at Month 6 Those Who Receive the Bed Scales at Baseline Are Expected to Have Increased Weight Loss

for
Disability Physical, Wheelchair, Obesity; Overweight
Location: Pittsburgh PA
Sponsor: Jonathan Pearlman

Sex: All

Age: 18+

Code: NCT07141342

Recruiting

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

for
Diabetes, Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06759701

Early Phase 1, Recruiting

Time-restricted Eating for Postpartum Weight Loss

for
Postpartum Weight Retention, Overweight and Obesity
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 18+

Code: NCT06491537

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention

for
Cardiovascular Disease, Obesity
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 19 - 70+

Code: NCT01927783

Recruiting

Control Systems Engineering for Weight Loss Maintenance

for
Overweight and Obesity
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 18 - 70

Code: NCT06244888

Phase 2, Recruiting

Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Female

Age: 18+

Code: NCT05930483

Recruiting

Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults

for
Obesity, Multiple Chronic Conditions
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 65 - 70+

Code: NCT06044571

Recruiting

EMPOWER: Effects of Weight Loss and Exercise Post-stroke

for
Obesity, Stroke
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 35 - 70+

Code: NCT05901675

Recruiting

Fluid Intake After Hemodialysis

for
Chronic Kidney Disease Requiring Chronic Dialysis,
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sex: All

Age: 18+

Code: NCT04721652

Recruiting

Interoceptive Exposure for Adolescents With Low Weight Eating Disorders

for
Anorexia Nervosa
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 12 - 18

Code: NCT05763849

Recruiting

Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy

for
Post Operative Pain, Laparoscopic Sleeve Gastrectomy,
Location: Cleveland OH
Sponsor: Ricard Corcelles

Sex: All

Age: 18 - 70

Code: NCT06425016

Recruiting

Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

for
Obesity, Chronic Kidney Disease
Location: London
Sponsor: Western University, Canada

Sex: All

Age: 18+

Code: NCT06396416

Recruiting

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders

for
Anorexia Nervosa
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 14 - 22

Code: NCT05554172

Recruiting

Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD

for
Chronic Kidney Diseases, Metabolic Acidosis, Fatigue,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 21 - 70+

Code: NCT04984226

Phase 2, Recruiting

Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

for
Shift Work Schedule, Circadian Rhythm, Insulin Resistance,
Location: Spokane WA
Sponsor: Washington State University

Sex: All

Age: 18 - 45

Code: NCT07494084

Recruiting

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

for
Heavy Menstrual Bleeding, Bleeding Disorder,
Location: Hershey PA, Kansas City MO, Aurora CO, Seattle WA,
Sponsor: Oregon Health and Science University

Sex: Female

Age: 10 - 24

Code: NCT05916469

Recruiting

HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB

for
Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB)
Location: Miami FL
Sponsor: Alnylam Pharmaceuticals

Sex: Female

Age: 16 - 45

Code: NCT07575308

Phase 2, Recruiting

Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management

for
Breast Cancer, Fatigue
Location: Morgantown WV
Sponsor: West Virginia University

Sex: Female

Age: 18+

Code: NCT06960720

Recruiting

What weight loss treatments are being studied

GLP-1 and combination medicines. The medicines that reshaped the field mimic a gut hormone called GLP-1 that signals fullness and slows digestion. Semaglutide (Wegovy) was approved for weight management in June 2021 and produced about 15 percent weight loss in its main trial; tirzepatide (Zepbound), which acts on GLP-1 and a second hormone, GIP, was approved in November 2023 and produced up to about 21 percent. Trials now test medicines that add a third hormone signal or pair a GLP-1 with amylin, another appetite hormone, aiming for larger and more durable weight loss; the CagriSema combination, for example, is under FDA review after Phase 3 trials, and its confirmatory studies are still enrolling.

Pills. For years every effective option was an injection. In December 2025 the FDA approved a semaglutide tablet (Wegovy pill), and on April 1, 2026 it approved orforglipron (Foundayo), the first GLP-1 pill that can be taken at any time without food or water restrictions, after trials in which people lost about 11 to 12 percent of body weight over 72 weeks. Current orforglipron trials test the pill in groups the approval studies did not cover, including adolescents and people who have already lost weight on an injection and want to maintain it.

Weight loss surgery. Bariatric surgery remains the most effective and longest lasting treatment for severe obesity, with roughly a quarter of a million operations performed in the US each year, most of them sleeve gastrectomy or gastric bypass. Trials study how surgery changes metabolism, how to prevent weight regain afterward, and how surgery compares with or combines with the new medicines.

Devices and endoscopic procedures. Between medicine and surgery sit procedures done through the mouth with no incision: endoscopic sleeve gastroplasty, which stitches the stomach smaller from the inside and was authorized by the FDA in 2022; intragastric balloons, which sit in the stomach for six months; and revision procedures for people who regained weight after bypass. Trials compare newer devices against established ones and measure how long results hold.

GLP-1 medication trials

Weight loss surgery and device trials

Who can participate in weight loss treatment trials

Do participants get paid?

How to enroll in a weight loss clinical trial